Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery

por Gandhi, S, Warltier, D, Weiskopf, R, Bepperling, F, Baus, D, Jungheinrich, C
Publicado 2005

Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomi...

por Grauer, MT, Baus, D, Woessner, R, Bepperling, F, Kahles, T, Georgi, S, Bianchi, O, Treib, J
Publicado 2001